Phase 1 Study of Alvelestat, an Oral Neutrophil Elastase Inhibitor, in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Johns Hopkins University, Johns Hopkins Medicine, Sibley Memorial Hospital, National Heart, Lung, and Blood Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097115279
